Research Gap Sample Clauses

Research Gap. Women with SMI are not receiving important SRH services, regarding STI testing and treatment (Xxxxxxx et al., 2012). Currently, there is insufficient qualitative information on mental health providers’ perceptions of whether, and to what extent, they can provide these specific medical services (Agenor & Xxxxxxx, 2013; Xxxxx, Xxxxxxx, & Xxxxxx, 2011). Comprehensive sexual and reproductive (SRH) medical care requires that the medical system and mental health system work closely together (Druss, 2007), creating a need to understand what enables and what inhibits psychiatrists from directly providing or connecting their female patients of reproductive age to SRH care. The findings from this study will help to guide interventions and facilitate change.
AutoNDA by SimpleDocs
Research Gap. This thesis is based on the working knowledge IT department of the company and study of which type of Management Information System is used to practice in the Nepalese Insurance Companies or especially in the Gurans Life Insurance Company Ltd. and which type of Management Information System should be used for the smooth running of insurance business. I have used different ERD, Flow Charts and DFD tools to make research useful. And there is not any research study on the topic of Management Information System in Insurance Companies. So, that this is the main feature of the thesis. But other portion of the thesis is same as the usual thesis.
Research Gap. Maternal mental health in pregnancy is an important correlate of maternal and child health outcomes (Xxxxxxx & Saftlas, 2008; World Health Organization, 2008). Literature on mental health in the Arab Middle East suggests higher levels of stress, anxiety, and depression among women as compared to men in the region (Xxxxx & Xxxxx, 2012). However, prenatal stress and other psychosocial correlates are understudied among pregnant Qatari women, as well as other women in Arab Middle Eastern populations.
Research Gap. Many studies were done on concentrating the different grading systems that can be used for diagnosis of keratoconus. Few studies are aimed to construct newer classification systems with different parameters for grading the severity of keratoconus. A study was done on the topographic and Pachymetric parameters of Scheimpflug system in Turkey populations. But there is lack of such on diagnosis criteria and classification system that can be used widely for detecting keratoconus in the early stage. There are no gold standard criteria, classification systems and imaging tools in diagnosing keratoconus. Hence the current study is aimed at checking the validity of topographic and Pachymetric indices using different imaging system with KISA% and Kmax/TP criteria and using Xxxxxx Xxxxxxxx and CLEK’s grading systems. There is need to find agreement between different criteria used in keratoconus diagnosis with the increasing severity of the condition.  Methodology  Subjects  Study design: Retrospective case control Study  Sampling technique: Purposive sampling  Study setting: Prasad Nethralaya, Udupi  Study participants: Patients diagnosed with Keratoconus and their age matched controls  Study duration: February 2016March 2017Sample size calculation: last 3 years data available in the instruments.  Inclusion criteria: Data of Subjects with keratoconus and subjects with normal cornea  Exclusion criteria: Data of Subjects with history of any other corneal pathologies or infections, recent contact lens use, past corneal surgeries.  Materials 1. Data from Corneal topography (Atlas, Carl Zeiss Meditec) and Pachymetry (Visante AS OCT, Zeiss) 2. Details of comprehensive examination which includes vision assessment, refractive error measurement, slit lamp biomicroscopy and fundus examination was retrieved from the files of Medical Records Department, Prasad Nethralaya, Udupi.  Procedure Permission from IRB and ethics committee was obtained for conducting the study. And also letter from Prasad Nethralaya stating the consent to procure the data needed for the study was obtained prior to the commencement of data collection. In this retrospective study, we collected information of 418 eyes (209 Keratoconus +209 ages matched controls). The demographic data of patients was drawn from the system. The corneal topographic and Pachymetric parameters was obtained from the Atlas corneal topography and AS OCT respectively from patients diagnosed with keratoconus and thei...

Related to Research Gap

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Research Project The findings of any research project, which would change the provisions of this Agreement will not be implemented until such changes are negotiated and agreed to by the parties.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!